CIPLA
|
The Current P/S Ratio of CIPLA is 4.46.
Share Price | ₹1,522.0 | Jun 11,2025 |
Market Cap | ₹122,927.9 Cr | |
Sales-TTM | ₹27,547.6 Cr | TTM-Consolidated Results |
Price/Sales | 4.46x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of CIPLA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹122,927.9 Cr] as on Jun 11,2025
(/) Sales [ ₹27,547.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.46x ]
Thus, for CIPLA , the investors are currently willing to pay '4.46 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CIPLA !
The chart below summarizes the trend in P/S Ratio of CIPLA over the last five years.
Historical PS (Price/Sales) ratio chart of CIPLA
PS Ratio Performance Analysis for CIPLA
- CIPLA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.41x.
- CIPLA 's operated at median p/e ratio of 3.43x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/e ratio peaked in Mar2024 at 4.68x.
- CIPLA 's p/e ratio hit its five-year low in Mar2020 of 1.99x.
How does CIPLA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
CIPLA | 27,547.6 | 4.46 | 122,927.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.72 | 405,824.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 19.06 | 178,355.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.42 | 108,502.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.45 | 112,701.0 |
MANKIND PHARMA LTD | 12,279.3 | 7.99 | 98,151.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.24 | 98,485.1 |
LUPIN LTD | 22,707.9 | 4.08 | 92,597.3 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.12 | 67,381.7 |
ABBOTT INDIA LTD | 6,409.2 | 10.48 | 67,196.8 |
ALKEM LABORATORIES LTD | 12,964.5 | 4.51 | 58,426.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CIPLA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.12x |
Max industry PS | 19.06x |
Median industry PS | 4.51x |
Average industry PS | 7.05x |
You may also like the below Video Courses